CD8A and viral infectious disease: Whereas NKG2D acts as a direct activator on NK cells, triggering cytotoxicity and cytokine secretion [175,176,177], Kennedy et al. demonstrated that it is a co-stimulatory molecule acting in synergy with the TCR on HBV-specific CD8+ T cells, similar to other viral infections [174,178].